Verdad Advisers, L.P. is an SEC-registered investment adviser based in Boston, MA that reports managing 7 hedge funds on Form ADV. It reports $1.2 billion in regulatory assets under management. Its private funds, of all types, hold $692.8 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +22.2% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +22.2% from Q1 2026 to Q2 2026, compared with +9.5% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $1.2 billionForm ADV Item 5.F
- Gross assets of private funds
- $692.8 millionAll private fund types, Form ADV
- Hedge funds managed
- 77 private funds in total
- Employees
- 8Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 171048
- Latest Form ADV
- 10/01/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +18.9% | +14.8% |
| Q1 2026 | +2.7% | -4.6% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
The 50 largest of 189 share positions ($93,200,800) reported by Verdad Advisers, LP on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- Apple Inc2.26%
- Visa Inc2.26%
- Fortinet Inc2.15%
- Acadia Pharmaceuticals Inc1.96%
- WW Grainger Inc1.87%
- Johnson & Johnson1.86%
- Bank Of NY Mellon Corp1.58%
- Spyglass Pharma Inc1.58%
- Autohome Inc1.44%
- Zymeworks Inc1.35%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| Apple Inc | $2,110,348 | 2.26% | 6,337 | -14.88% |
| Visa Inc | $2,108,189 | 2.26% | 5,867 | New |
| Fortinet Inc | $2,001,754 | 2.15% | 11,198 | New |
| Acadia Pharmaceuticals Inc | $1,825,247 | 1.96% | 90,583 | +9.63% |
| WW Grainger Inc | $1,744,064 | 1.87% | 1,400 | New |
| Johnson & Johnson | $1,737,753 | 1.86% | 6,564 | +21.92% |
| Bank Of NY Mellon Corp | $1,475,805 | 1.58% | 10,204 | +77.52% |
| Spyglass Pharma Inc | $1,474,408 | 1.58% | 56,708 | New |
| Autohome Inc | $1,337,858 | 1.44% | 62,958 | New |
| Zymeworks Inc | $1,256,686 | 1.35% | 47,440 | -28.86% |
| State STR Corp | $1,240,462 | 1.33% | 7,105 | New |
| Chevron Corporation | $1,230,978 | 1.32% | 6,028 | New |
| Contineum Therapeutics Inc | $1,211,356 | 1.30% | 90,265 | +11.42% |
| Valero Energy Corp | $1,207,018 | 1.30% | 3,114 | New |
| LB Pharmaceuticals Inc | $1,128,065 | 1.21% | 29,392 | +328.02% |
| Exelixis Inc | $1,075,211 | 1.15% | 18,408 | New |
| Netscout SYS Inc | $1,073,690 | 1.15% | 26,722 | -19.34% |
| Protara Therapeutics Inc | $1,073,606 | 1.15% | 352,002 | +12.73% |
| Hewlett Packard Enterprise C | $1,068,049 | 1.15% | 16,717 | New |
| PC Connection Inc | $1,058,217 | 1.14% | 11,728 | +5.81% |
| Hello Group Inc | $1,055,648 | 1.13% | 218,109 | +157.55% |
| Roku Inc | $996,520 | 1.07% | 6,544 | New |
| Spero Therapeutics Inc | $974,900 | 1.05% | 805,702 | +1,469.50% |
| Fastenal Co | $967,668 | 1.04% | 19,537 | New |
| Airbnb Inc | $940,124 | 1.01% | 5,852 | New |
| X4 Pharmaceuticals Inc | $937,181 | 1.01% | 323,166 | -8.22% |
| Oppenheimer Hldgs Inc | $928,699 | 1.00% | 7,873 | -9.22% |
| Cisco SYS Inc | $928,201 | 1.00% | 8,624 | -16.33% |
| Allstate Corp | $887,440 | 0.95% | 4,000 | +21.99% |
| Pattern Group Inc | $840,926 | 0.90% | 49,005 | New |
| Sei Invts Co | $821,485 | 0.88% | 8,002 | New |
| Janux Therapeutics Inc | $820,437 | 0.88% | 47,479 | +17.56% |
| Netapp Inc | $800,405 | 0.86% | 3,810 | New |
| Jade Biosciences Inc | $792,097 | 0.85% | 56,377 | Unchanged |
| Chime Finl Inc | $786,280 | 0.84% | 29,515 | New |
| Hinge Health Inc | $773,933 | 0.83% | 7,959 | New |
| Celldex Therapeutics Inc New | $759,982 | 0.82% | 23,449 | +13.26% |
| Movado Group Inc | $750,963 | 0.81% | 22,565 | +20.27% |
| Ethos Technologies Inc | $737,566 | 0.79% | 21,971 | New |
| Septerna Inc | $720,109 | 0.77% | 18,403 | +41.89% |
| Appfolio Inc | $702,021 | 0.75% | 3,501 | New |
| MSC Indl Direct Inc | $700,998 | 0.75% | 5,666 | New |
| Edgewise Therapeutics Inc | $690,687 | 0.74% | 17,012 | -37.53% |
| Ooma Inc | $687,980 | 0.74% | 33,675 | +2.64% |
| Monopar Therapeutics Inc | $669,945 | 0.72% | 8,409 | New |
| Belite Bio Inc | $644,467 | 0.69% | 3,795 | -72.42% |
| TD Synnex Corporation | $639,300 | 0.69% | 2,489 | -10.47% |
| Crowdstrike Hldgs Inc | $636,459 | 0.68% | 2,404 | New |
| Red Violet Inc | $621,967 | 0.67% | 7,872 | New |
| Target Corp | $608,741 | 0.65% | 3,885 | New |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 86 new positions, 107 sold out, 32 increased, 59 reduced and 12 unchanged.
Number of positions (a count, not dollars)
- New positions86
- Increased32
- Unchanged12
- Reduced59
- Sold out107
New positions
| Stock | Value | Shares |
|---|---|---|
| Visa Inc | $2,108,189 | 5,867 |
| Fortinet Inc | $2,001,754 | 11,198 |
| WW Grainger Inc | $1,744,064 | 1,400 |
| Spyglass Pharma Inc | $1,474,408 | 56,708 |
| Autohome Inc | $1,337,858 | 62,958 |
| State STR Corp | $1,240,462 | 7,105 |
| Chevron Corporation | $1,230,978 | 6,028 |
| Valero Energy Corp | $1,207,018 | 3,114 |
| Exelixis Inc | $1,075,211 | 18,408 |
| Hewlett Packard Enterprise C | $1,068,049 | 16,717 |
| Roku Inc | $996,520 | 6,544 |
| Fastenal Co | $967,668 | 19,537 |
| Airbnb Inc | $940,124 | 5,852 |
| Pattern Group Inc | $840,926 | 49,005 |
| Sei Invts Co | $821,485 | 8,002 |
| Netapp Inc | $800,405 | 3,810 |
| Chime Finl Inc | $786,280 | 29,515 |
| Hinge Health Inc | $773,933 | 7,959 |
| Ethos Technologies Inc | $737,566 | 21,971 |
| Appfolio Inc | $702,021 | 3,501 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Comcast Corp New | $2,076,169 | 84,569 |
| Chatham Lodging TR | $1,852,200 | 140,000 |
| Amn Healthcare Svcs Inc | $1,680,197 | 51,906 |
| Versant Media Group Inc | $1,566,543 | 43,503 |
| Bloomin Brands Inc | $1,188,200 | 130,000 |
| Par Pac Holdings Inc | $1,121,600 | 20,000 |
| Carters Inc | $1,029,000 | 25,000 |
| Vera Therapeutics Inc | $1,007,827 | 23,487 |
| Nuvalent Inc | $1,000,844 | 8,104 |
| Dianthus Therapeutics Inc | $980,844 | 10,062 |
| Myers Inds Inc | $865,095 | 24,500 |
| Adapthealth Corp | $781,500 | 75,000 |
| Heritage Insurance Hldgs Inc | $745,236 | 28,575 |
| Smart Sand Inc | $714,847 | 142,684 |
| Viridian Therapeutics Inc | $711,323 | 38,722 |
| Design Therapeutics Inc | $688,150 | 47,557 |
| Mativ Holdings Inc | $681,300 | 90,000 |
| Stonex Group Inc | $673,317 | 5,682 |
| Rocky Brands Inc | $629,075 | 15,254 |
| Avalo Therapeutics Inc | $606,643 | 32,827 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Spero Therapeutics Inc | +754,367 | +1,469.50% | $974,900 | 805,702 |
| LB Pharmaceuticals Inc | +22,525 | +328.02% | $1,128,065 | 29,392 |
| Hello Group Inc | +133,424 | +157.55% | $1,055,648 | 218,109 |
| Bank Of NY Mellon Corp | +4,456 | +77.52% | $1,475,805 | 10,204 |
| Context Therapeutics Inc | +1,099,435 | +3,243.17% | $340,454 | 1,133,335 |
| Johnson & Johnson | +1,180 | +21.92% | $1,737,753 | 6,564 |
| VTV Therapeutics Inc | +6,974 | +77.52% | $492,515 | 15,970 |
| Septerna Inc | +5,433 | +41.89% | $720,109 | 18,403 |
| Vistagen Therapeutics Inc | +672,605 | +229.29% | $297,319 | 965,948 |
| Kalaris Therapeutics Inc | +59,935 | +74.64% | $405,270 | 140,232 |
| Acadia Pharmaceuticals Inc | +7,954 | +9.63% | $1,825,247 | 90,583 |
| Allstate Corp | +721 | +21.99% | $887,440 | 4,000 |
| Adicet Bio Inc | +22,346 | +88.67% | $339,478 | 47,546 |
| Lam Research Corp | +454 | +50.84% | $442,503 | 1,347 |
| Movado Group Inc | +3,803 | +20.27% | $750,963 | 22,565 |
| Contineum Therapeutics Inc | +9,251 | +11.42% | $1,211,356 | 90,265 |
| Passage Bio Inc | +27,269 | +88.74% | $260,987 | 57,997 |
| Janux Therapeutics Inc | +7,093 | +17.56% | $820,437 | 47,479 |
| Protara Therapeutics Inc | +39,753 | +12.73% | $1,073,606 | 352,002 |
| RMR Group Inc | +6,691 | +29.74% | $527,701 | 29,187 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Belite Bio Inc | -9,963 | -72.42% | $644,467 | 3,795 |
| Slide Ins Hldgs Inc | -68,397 | -75.10% | $505,835 | 22,673 |
| Nurix Therapeutics Inc | -27,300 | -55.14% | $526,623 | 22,211 |
| Geron Corp | -470,299 | -95.16% | $29,399 | 23,902 |
| Whitehawk Therapeutics Inc | -147,785 | -49.02% | $577,904 | 153,698 |
| Aclaris Therapeutics Inc | -104,838 | -59.81% | $370,483 | 70,434 |
| Verizon Communications Inc | -11,832 | -56.51% | $417,692 | 9,106 |
| American Integrity Ins Group | -21,046 | -49.90% | $528,089 | 21,132 |
| Zymeworks Inc | -19,248 | -28.86% | $1,256,686 | 47,440 |
| Alphabet Inc | -1,315 | -45.34% | $545,367 | 1,585 |
| Tyra Biosciences Inc | -20,290 | -56.36% | $343,643 | 15,713 |
| Revolution Medicines Inc | -2,139 | -52.78% | $392,868 | 1,914 |
| Edgewise Therapeutics Inc | -10,222 | -37.53% | $690,687 | 17,012 |
| Apple Inc | -1,108 | -14.88% | $2,110,348 | 6,337 |
| Universal Ins Hldgs Inc | -8,371 | -40.72% | $512,951 | 12,187 |
| Netscout SYS Inc | -6,406 | -19.34% | $1,073,690 | 26,722 |
| Relmada Therapeutics Inc | -61,170 | -70.32% | $97,356 | 25,824 |
| Zoom Communications Inc | -2,300 | -32.28% | $437,965 | 4,825 |
| Applied Matls Inc | -401 | -36.82% | $351,829 | 688 |
| Fulcrum Therapeutics Inc | -52,320 | -41.78% | $269,745 | 72,904 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Hedge funds filing Form D (7)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private funds reported on Form ADV (6)
As reported in the adviser's Form ADV filed Mar 12, 2024. Funds also listed from Form D are shown above.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures